为探究狼疮（SLE）患者患 IgA 肾病（IgAN）的临床特征及预后，研究对比相关患者，发现 SLE-IgAN 有独特特点，对诊疗意义重大。 狼疮，一种神秘的自身免疫性疾病，就像身体里的 “捣乱分子”，会攻击多个系统，尤其是肾脏，引发狼疮性肾炎（LN）。而 IgA 肾病 ...

Received Clearance from the U.S. Food and Drug Administration (FDA) for Clinical Trials of Budoprutug in Primary Membranous Nephropathy (pMN), ...

Received Clearance from the U.S. Food and Drug Administration (FDA) for Clinical Trials of Budoprutug in Primary Membranous Nephropathy (pMN), Immune Thrombocytopenia (ITP), and Systemic Lupus Erythem ...

The new data – in rare kidney disease IgA nephropathy (IgAN) – comes from the APPLAUSE-IgAN study, with iptacopan achieving a "clinically meaningful and highly statistically significant ...

Fibroblast activating protein inhibitor (FAPI) PET/CT imaging may be a non-invasive modality to monitor IgA nephropathy (IgAN) progression, preliminary study results suggest.

IgA Nephropathy Foundation Leadership and IgAN Patients pose for a photo at SPARK IgA Nephropathy Foundation celebrates 20 years of advocac ...

Biogen has revealed encouraging phase 2 results with its anti-CD38 antibody felzartamab in rare kidney disease IgA nephropathy (IgAN), which it hopes could join a series of first-in-class ...

Immunoglobulin A (IgA) nephropathy is a condition that causes a certain type of protein to build up in your kidneys. It progresses differently in everyone. Your kidneys might still work well years ...

Immunoglobulin A (IgA) nephropathy, also called Berger’s disease, is an autoimmune disease that affects your kidneys. IgA is an antibody. Antibodies are proteins made by your immune system.